Category: Drug Safety Alerts
-
Women Using Cordarone Five Times More Likely To Need Pacemaker Than Women Who Did Not
Researchers Find There Is No Such Risk, However, For Men Using This Atrial Fibrillation Heart Drug (Posted by Tom Lamb at DrugInjuryWatch.com) An August 14, 2007 article published by Reuters, "Heart drug may lead…
-
Australian Regulators Request That Novartis Withdraw Their Painkiller Drug Prexige
Prexige Associated With Reports Of Liver Damage, Liver Transplants, And Death (Posted by Tom Lamb at DrugInjuryWatch.com) An August 11, 2007 Bloomberg article, "Novartis’ Prexige Painkiller Drug Pulled by Australia", let us know about…
-
FDA / Health Canada: Long Term Use Of Nexium And Prilosec May Cause Heart Attacks Or Cardiac Death
AstraZeneca Study Information Provided To Regulatory Agencies In May 2007 Currently The Subject of Their Ongoing Safety Reviews (Posted by Tom Lamb at DrugInjuryWatch.com) On August 9, 2007 the FDA and Health Canada issued…
-
Drug Safety Update: A Promising New Monthly Electronic Bulletin From The UK’s Drug Agency
First Issue Includes Updated Advice Regarding Dostinex; Now A Second-Line Treatment Due To Increased Risk Of Serious Heart Valve Damage (Posted by Tom Lamb at DrugInjuryWatch.com) In the United Kingdom (UK) the Medicines and…
-
Latest Avandia Heart Risk Findings Reported In July 5, 2007 NEJM Edition
Avandia Seems Associated With Increased Rate Of Heart Failure; Less Clear Whether Glaxo’s Diabetes Drug Causes Heart Attacks, Other Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com) In the July 5, 2007 edition of…
-
Black-Box Warning About Anaphylaxis Being Put On Asthma Drug Xolair
Potentially Deadly Allergic Reaction Occurs Twice As Often As Previously Stated On Medication's Prior Label (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA announced on July 2, 2007 that the package insert, or label,…
-
Following FDA’s Action, Novartis’ Zelnorm Gets Recall Order From Chinese Drug Regulator
China’s State Food & Drug Administration Says Zelnorm Side Effect Risks Outweigh This Drug’s Benefits (Posted by Tom Lamb at DrugInjuryWatch.com) A June 8, 2007 Associated Press (AP) article published in The Washington Post…
-
Emerging Drug Safety Issue Regarding Abbott’s TriCor Triglycerides Medication
Barron’s June 2007 Report: Experts Are Concerned That TriCor May Cause Decline In Kidney Functions (Posted by Tom Lamb at DrugInjuryWatch.com) The weekly business newspaper Barron’s reported on June 3, 2007 that some expert…
-
The Avandia Heart Attack Risk Was Raised To FDA Back In 2000; Will Agency Wait Until 2009 To Act?
In Comparison, Europe’s Regulators Had Glaxo Change Avandia Label In 2006 To Include Warning About Risk Of Cardiac Ischemic Events Such As Heart Attacks (Posted by Tom Lamb at DrugInjuryWatch.com) In a May 24,…